Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
about
Docking Screens for Novel Ligands Conferring New Biology.Identification of novel inhibitors of the amino acid transporter B0 AT1 (SLC6A19), a potential target to induce protein restriction and to treat type 2 diabetes.Computing Substrate Selectivity in a Peptide Transporter.From Krebs to clinic: glutamine metabolism to cancer therapy.Attacking the supply wagons to starve cancer cells to death.Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual ScreeningSLC Transporters: Structure, Function, and Drug Discovery.Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2.Rosetta Broker for membrane protein structure prediction: concentrative nucleoside transporter 3 and corticotropin-releasing factor receptor 1 test cases.Drug-induced amino acid deprivation as strategy for cancer therapy.Glutamine transporters in mammalian cells and their functions in physiology and cancer.Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5.Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth.Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
P2860
Q30489011-C3106622-BA07-4AA7-B665-90E5BE59A708Q32182366-DF6170BA-70DC-4218-A742-8D279828A478Q33760314-AA297FA5-44B4-4C7B-87C3-2DC20CA62FF9Q33834498-D0B76DD7-3B41-4108-85A5-A53982FADEC2Q34516773-1CB6DCF7-58D5-4B6F-A6D4-3C3F81160C6FQ36003519-8F1958D1-3CEA-41B4-B3DA-29A0E772BCDDQ37279747-9C322A47-BF1C-4267-BCFD-9D4BDB6E073FQ37717638-BBFD8365-5557-4C4B-8C34-E2023DA67BE2Q38642901-13595886-9DF7-4C78-B16E-7F887BDEAFB7Q38657061-7942500F-9923-4D3E-B928-1231082905A2Q38685207-00FCC7CE-81D1-4182-A322-016BE00AC571Q47431439-7BE465E3-C2A3-4F4A-B7DA-4EFB5720D0BEQ47754240-D8F2A28A-BCD9-472A-9F9E-774BD881B5A5Q49627330-E1A2F9E2-0EE4-413A-9122-7413810419C1Q57174877-7F3E766B-5F27-4332-A2E9-48F7AF73F5B5Q58764807-A479A3C2-DF17-48EA-BC42-FFBA6C736A3E
P2860
Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@ast
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@en
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@nl
type
label
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@ast
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@en
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@nl
prefLabel
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@ast
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@en
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@nl
P2093
P2860
P1476
Ligand Discovery for the Alani ...... Modeling and Virtual Screening
@en
P2093
Armanda Gameiro
Avner Schlessinger
Christof Grewer
Claire Colas
Helen Shere
Kurnvir Singh
Massimiliano Bonomi
Nicholas James Otte
Thomas Albers
P2860
P304
P356
10.1371/JOURNAL.PCBI.1004477
P407
P577
2015-10-01T00:00:00Z